Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15983 | 28627263 | Arch Physiol Biochem | Association of interleukin-1A insertion/deletion gene polymorphism and possible high risk factors with non-alcoholic fatty liver disease in Egyptian patients. | 2017 | Details |
| A15991 | 28623125 | Biochem Biophys Res Commun | Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways. | 2017 | Details |
| A15995 | 28621554 | Expert Rev Gastroenterol Hepatol | Gut microbiota changes and chronic hepatitis C virus infection. | 2017 | Details |
| A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
| A16006 | 28615649 | Sci Rep | Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A16017 | 28609252 | Gut Microbes | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | 2017 | Details |
| A16018 | 28608850 | Nat Commun | Cellular senescence drives age-dependent hepatic steatosis. | 2017 | Details |
| A16019 | 28608557 | J Food Sci | Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet. | 2017 | Details |
| A16025 | 28604704 | Nat Med | Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. | 2017 | Details |
| A16026 | 28603092 | Hepatobiliary Pancreat Dis Int | Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance. | 2017 | Details |
| A16027 | 28602867 | J Ethnopharmacol | Effect of Gangjihwan on hepatic steatosis and inflammation in high fat diet-fed mice. | 2017 | Details |
| A16034 | 28598982 | PLoS One | α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. | 2017 | Details |
| A16042 | 28596431 | Eur Respir J | Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. | 2017 | Details |
| A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
| A16047 | 28595079 | Int Immunopharmacol | Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling. | 2017 | Details |
| A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
| A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
| A16055 | 28591717 | Oncotarget | Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet. | 2017 | Details |
| A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
| A16061 | 28587303 | Children (Basel) | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16063 | 28587078 | Nutrients | Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16095 | 28573069 | World J Gastrointest Pathophysiol | Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. | 2017 | Details |
| A16097 | 28573066 | World J Gastrointest Pathophysiol | Embrionary way to create a fatty liver in portal hypertension. | 2017 | Details |
| A16100 | 28571771 | Food Chem Toxicol | The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice. | 2017 | Details |
| A16102 | 28570941 | J Nutr Biochem | Diet-dependent retinoid effects on liver gene expression include stellate and inflammation markers and parallel effects of the nuclear repressor Shp. | 2017 | Details |
| A16114 | 28559541 | Int J Obes (Lond) | Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. | 2017 | Details |
| A16119 | 28555525 | Immunopharmacol Immunotoxicol | Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. | 2017 | Details |
| A16123 | 28551086 | Redox Biol | HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. | 2017 | Details |
| A16125 | 28550391 | Hepatol Int | Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. | 2017 | Details |
| A16130 | 28547778 | FEBS Lett | Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice. | 2017 | Details |
| A16148 | 28538192 | Biomed Pharmacother | Hepatic anti-inflammatory effect of hexane extracts of Dioscorea batatas Decne: Possible suppression of toll-like receptor 4-mediated signaling. | 2017 | Details |
| A16151 | 28536464 | Sci Rep | The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A. | 2017 | Details |
| A16168 | 28526997 | Adv Ther | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. | 2017 | Details |
| A16176 | 28521774 | J Transl Med | Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease. | 2017 | Details |
| A16188 | 28511199 | Inflamm Bowel Dis | Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. | 2017 | Details |
| A16199 | 28508193 | Endocrine | Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice. | 2017 | Details |
| A16202 | 28507837 | Cureus | Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias. | 2017 | Details |
| A16203 | 28507473 | EXCLI J | Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. | 2017 | Details |
| A16209 | 28506362 | Gastroenterol Clin North Am | Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16212 | 28505074 | Nutrients | NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. | 2017 | Details |
| A16213 | 28504910 | J Med Food | Fermented Moringa oleifera Decreases Hepatic Adiposity and Ameliorates Glucose Intolerance in High-Fat Diet-Induced Obese Mice. | 2017 | Details |
| A16215 | 28504310 | J Physiol | Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis. | 2017 | Details |
| A16224 | 28501537 | Clin Gastroenterol Hepatol | Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. | 2017 | Details |
| A16225 | 28501229 | Prim Care | Integrative Medicine for Gastrointestinal Disease. | 2017 | Details |
| A16226 | 28500084 | J Endocrinol | Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice. | 2017 | Details |
| A16227 | 28499273 | Oncotarget | Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development. | 2017 | Details |
| A16233 | 28494548 | Zhonghua Gan Zang Bing Za Zhi | [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis]. | 2017 | Details |
| A16245 | 28486193 | Biomed Pharmacother | Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro. | 2017 | Details |
| A16247 | 28484247 | Sci Rep | Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. | 2017 | Details |
| A16282 | 28471828 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes. | 2017 | Details |
| A16285 | 28471490 | Br J Pharmacol | Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease. | 2017 | Details |
| A16301 | 28468933 | J Endocrinol | The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. | 2017 | Details |
| A16332 | 28454924 | Toxicol Appl Pharmacol | Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. | 2017 | Details |
| A16336 | 28452101 | Diabetes Obes Metab | Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. | 2017 | Details |
| A16352 | 28442507 | J Endocrinol | Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. | 2017 | Details |
| A16360 | 28437890 | Biomed Pharmacother | Does propolis have any effect on non-alcoholic fatty liver disease? | 2017 | Details |
| A16393 | 28420164 | Int J Mol Sci | The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function. | 2017 | Details |
| A16395 | 28419855 | Clin Gastroenterol Hepatol | A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16402 | 28416740 | Oncotarget | Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A16410 | 28411553 | Biomed Pharmacother | Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. | 2017 | Details |
| A16423 | 28402022 | J Cell Biochem | Steroidogenic Acute Regulatory Protein (StAR) Overexpression Reduces Inflammation and Insulin Resistance in Obese Mice. | 2017 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16442 | 28386616 | Food Funct | Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation. | 2017 | Details |
| A16443 | 28384519 | J Nutr Biochem | Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. | 2017 | Details |
| A16444 | 28383715 | Nutr Rev | Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. | 2017 | Details |
| A16445 | 28382402 | J Gastroenterol | A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. | 2017 | Details |
| A16455 | 28376573 | Aust Fam Physician | The gut microbiome. | 2017 | Details |
| A16457 | 28376109 | PLoS One | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis. | 2017 | Details |
| A16462 | 28373874 | Front Immunol | Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration. | 2017 | Details |
| A16473 | 28368286 | J Clin Invest | Distinct but complementary contributions of PPAR isotypes to energy homeostasis. | 2017 | Details |
| A16478 | 28365312 | J Hepatol | Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. | 2017 | Details |
| A16495 | 28356106 | Lipids Health Dis | Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. | 2017 | Details |
| A16515 | 28346237 | Curr Opin Gastroenterol | Current and future pharmacologic treatment of nonalcoholic steatohepatitis. | 2017 | Details |
| A16517 | 28345499 | Br J Nutr | Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. | 2017 | Details |
| A16518 | 28344991 | Mol Ther Methods Clin Dev | Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes. | 2016 | Details |
| A16520 | 28341541 | Mol Aspects Med | Pro-resolving actions of SPM in adipose tissue biology. | 2017 | Details |
| A16523 | 28338115 | J Gastrointestin Liver Dis | Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. | 2017 | Details |
| A16529 | 28334911 | Hum Mol Genet | MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat. | 2017 | Details |
| A16540 | 28325574 | J Chin Med Assoc | Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury. | 2017 | Details |
| A16547 | 28323124 | J Hepatol | CD44 is a key player in non-alcoholic steatohepatitis. | 2017 | Details |
| A16549 | 28322783 | Biochem Biophys Res Commun | Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model. | 2017 | Details |
| A16554 | 28319060 | Oncogene | The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. | 2017 | Details |
| A16557 | 28318525 | Actas Dermosifiliogr | Psoriasis and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16563 | 28314735 | Gut | Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. | 2017 | Details |
| A16564 | 28306139 | Br J Pharmacol | The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation. | 2017 | Details |
| A16566 | 28303724 | Drug Metab Rev | Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. | 2017 | Details |
| A16568 | 28300221 | Sci Rep | Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. | 2017 | Details |
| A16569 | 28300213 | Sci Rep | Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. | 2017 | Details |
| A16570 | 28300161 | Sci Rep | FOXO transcription factors protect against the diet-induced fatty liver disease. | 2017 | Details |
| A16581 | 28297801 | Zhonghua Gan Zang Bing Za Zhi | [Effect of curcumin on intestinal mucosal mechanical barrier in rats with non-alcoholic fatty liver disease]. | 2017 | Details |
| A16591 | 28294699 | J Med Food | Chia Oil-Enriched Restructured Pork Effects on Oxidative and Inflammatory Status of Aged Rats Fed High Cholesterol/High Fat Diets. | 2017 | Details |
| A16600 | 28290049 | Curr Diab Rep | Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. | 2017 | Details |
| A16605 | 28286271 | Biochem Biophys Res Commun | p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. | 2017 | Details |
| A16609 | 28285394 | Inflamm Res | HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. | 2017 | Details |
| A16612 | 28283691 | Internist (Berl) | [Modulation of the intestinal microbiota by nutritional interventions]. | 2017 | Details |
| A16616 | 28281517 | Ter Arkh | [Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency]. | 2017 | Details |
| A16617 | 28281516 | Ter Arkh | [Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease]. | 2017 | Details |
| A16620 | 28281237 | Obes Surg | Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. | 2017 | Details |
| A16639 | 28270882 | J Clin Med Res | Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment. | 2017 | Details |